Potassium Magnesium Citrate Is Superior to Potassium Chloride in Reversing Metabolic Side Effects of Chlorthalidone.

Author: GiaconaJohn M, JohnsonTalon, KhanGhazi, MoeOrson W, MurilloAshley, PakCharles C Y, PittmanDanielle, RenJimin, VongpatanasinWanpen, WangJijia

Paper Details 
Original Abstract of the Article :
Thiazide diuretics (TD) are the first-line treatment of hypertension because of its consistent benefit in lowering blood pressure and cardiovascular risk. TD is also known to cause an excess risk of diabetes, which may limit long-term use. Although potassium (K) depletion was thought to be the main ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1161/HYPERTENSIONAHA.123.21932

データ提供:米国国立医学図書館(NLM)

Potassium Magnesium Citrate: A Superior Choice for Reversing Chlorthalidone's Metabolic Side Effects?

Thiazide diuretics (TDs), commonly used to lower blood pressure, can have metabolic side effects, including hyperglycemia, which can limit their long-term use. This research investigates the effects of potassium magnesium citrate (KMgCit) in reversing the metabolic side effects of chlorthalidone, a commonly prescribed TD.

Examining the Effects of KMgCit on Chlorthalidone's Metabolic Side Effects

The study examined the effects of KMgCit on fasting plasma glucose and liver fat in patients receiving chlorthalidone therapy. Researchers aimed to determine whether KMgCit could effectively mitigate the metabolic side effects associated with TD use, offering a potentially safer approach to managing hypertension.

KMgCit: A Potential for Improved Metabolic Outcomes

The study's findings suggest that KMgCit may be superior to potassium chloride in reversing the metabolic side effects of chlorthalidone. The researchers observed improvements in fasting plasma glucose and liver fat levels in patients receiving KMgCit, highlighting its potential as a valuable adjunct to TD therapy.

Dr.Camel's Conclusion

Finding a way to manage hypertension without sacrificing metabolic health is like discovering a hidden oasis in the desert of cardiovascular disease. This study suggests that KMgCit might offer a safer and more effective approach to managing the metabolic side effects of chlorthalidone, providing a more balanced approach to hypertension treatment.

Date :
  1. Date Completed 2023-11-28
  2. Date Revised 2023-11-28
Further Info :

Pubmed ID

37846572

DOI: Digital Object Identifier

10.1161/HYPERTENSIONAHA.123.21932

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.